TL13-12

• Description:

  TL13-12 is a novel Anaplastic Lymphoma Kinase (ALK) -PROTAC developed through conjugation of TAE684 and the cereblon ligand pomalidomide.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  961.489

• Molecular Formula:

  C45H53ClN10O10S

• Notes:

  Research use only, not for human use.

• Receptor:

  PROTAC

• CAS Number:

  2229037-04-9